Inventor · disambiguated record
Alastair David Griffiths Lawson
Also filed as: LAWSON ALASTAIR · LAWSON ALASTAIR D G · LAWSON ALASTAIR DAVID GRIFFITH · LAWSON ALASTAIR DAVID GRIFFITHS
48 granted patents·21 pending applications·852 citations·filing 1976–2025
98Inventor score
Files withUCB Biopharma SRL22UCB PHARMA SA11UCB BIOPHARMA SPRL10LAWSON ALASTAIR DAVID GRIFFITHS5CELLTECH R&D LTD4
Top patents by PatentIndex Score
69 records- 0198US7052906B1Synthetic transmembrane componentsCELLTECH R&D LTD·Filed 2000·Granted May 30, 2006·257 cites·10 claims
- 0297US7872106B2Sclerostin-binding antibodiesAMGEN INC·Filed 2008·Granted Jan 18, 2011·86 cites·25 claims
- 0396US10705094B2TNF receptor signaling modulator assayUCB Biopharma SRL·Filed 2015·Granted Jul 7, 2020·9 cites·18 claims
- 0496US7592429B2Sclerostin-binding antibodyUCB SA·Filed 2006·Granted Sep 22, 2009·166 cites·5 claims
- 0595US10883996B2Methods of identifying signaling modulators of the trimeric TNFaUCB Biopharma SRL·Filed 2015·Granted Jan 5, 2021·7 cites·5 claims
- 0695US8926977B2Antibodies to the E1 extracellular loop of ion channelsMILLER KAREN MARGRETE·Filed 2010·Granted Jan 6, 2015·100 cites·9 claims
- 0794US8614295B2Antibody molecules having specificity for human OX40LAWSON ALASTAIR DAVID GRIFFITHS·Filed 2010·Granted Dec 24, 2013·41 cites·29 claims
- 0893US11448655B2Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptorsUCB Biopharma SRL·Filed 2020·Granted Sep 20, 2022·2 cites·17 claims
- 0993US11022614B2Antibodies binding to trimeric TNF alpha epitopesUCB Biopharma SRL·Filed 2015·Granted Jun 1, 2021·5 cites·17 claims
- 1093US10969393B2Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding themUCB Biopharma SRL·Filed 2015·Granted Apr 6, 2021·5 cites·11 claims
- 1193US10775385B2Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimersUCB BIOPHARMA SPRL·Filed 2015·Granted Sep 15, 2020·7 cites·4 claims
- 1292US11674967B2Method of identifying potential inhibitors of APO TNFα trimersUCB Biopharma SRL·Filed 2020·Granted Jun 13, 2023·2 cites·19 claims
- 1391US9428570B2Antibody molecules having specificity for human OX40UCB PHARMA SA·Filed 2013·Granted Aug 30, 2016·18 cites·22 claims
- 1491US8507654B2Altered antibodiesBAKER TERENCE S·Filed 2007·Granted Aug 13, 2013·14 cites·9 claims
- 1589US2025012807A1Mechanism of actionUCB Biopharma SRL·Filed 2024·Application pending·0 cites
- 1688US12055549B2Methods of use of anti-TNFα antibodiesUCB Biopharma SRL·Filed 2021·Granted Aug 6, 2024·1 cites·16 claims
- 1788US10233243B2Anti-FcRn antibodiesUCB BIOPHARMA SPRL·Filed 2013·Granted Mar 19, 2019·10 cites·17 claims
- 1888US9266953B2Methods of treating pain using function modifying NAv1.7 antibodiesUCB BIOPHARMA SPRL·Filed 2014·Granted Feb 23, 2016·8 cites·8 claims
- 1988US8734798B2Function modifying NAv 1.7 antibodiesFINNEY HELENE MARGARET·Filed 2010·Granted May 27, 2014·16 cites·23 claims
- 2088US2024376191A1Antibody molecules which bind il-17a and il-17fUCB Biopharma SRL·Filed 2024·Application pending·0 cites
- 2187US8003108B2Sclerostin epitopesAMGEN INC·Filed 2006·Granted Aug 23, 2011·11 cites·15 claims
- 2286US11174311B2Antibody against trimeric TNFα complexUCB Biopharma SRL·Filed 2017·Granted Nov 16, 2021·4 cites·14 claims
- 2386US8986954B2DNA encoding function modifying Nav1.7 antibodiesUCB PHARMA SA·Filed 2014·Granted Mar 24, 2015·6 cites·6 claims
- 2486US7993864B2Assay for identifying antibody producing cellsUCB PHARMA SA·Filed 2003·Granted Aug 9, 2011·20 cites·17 claims
- 2585US12474348B2Complexes between CD40 and compounds comprising benzimidazole moietiesUCB Biopharma SRL·Filed 2022·Granted Nov 18, 2025·0 cites·6 claims
- 2683US2025346672A1Anti-fcrn antibodiesUCB Biopharma SRL·Filed 2025·Application pending·0 cites
- 2782US9988446B2Methods of treatment using antibodies which bind IL-17A and IL-17FUCB BIOPHARMA SPRL·Filed 2015·Granted Jun 5, 2018·2 cites·26 claims
- 2881US9957320B2Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13UCB BIOPHARMA SPRL·Filed 2016·Granted May 1, 2018·3 cites·8 claims
- 2981US8465744B2Method of treating inflammation by administering human IL-1B antibodiesLAWSON ALASTAIR DAVID GRIFFITHS·Filed 2009·Granted Jun 18, 2013·4 cites·20 claims
- 3080US12338285B2Anti-FcRn antibodiesUCB Biopharma SRL·Filed 2022·Granted Jun 24, 2025·0 cites·52 claims
- 3180US11384148B2Anti-FcRn antibodiesUCB BIOPHARMA SPRL·Filed 2019·Granted Jul 12, 2022·1 cites·16 claims
- 3280US9394361B2Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13UCB PHARMA SA·Filed 2014·Granted Jul 19, 2016·4 cites·9 claims
- 3380US7052876B1Combinatorial method for producing nucleic acidsCELLTECH THERAPEUTICS LTD·Filed 2000·Granted May 30, 2006·6 cites·40 claims
- 3479US8691233B2Antibody molecules having binding specificity for human IL-13GOZZARD NEIL·Filed 2010·Granted Apr 8, 2014·7 cites·12 claims
- 3578US11919950B2Expression vector encoding antibody molecule which binds IL-17A and IL-17FUCB Biopharma SRL·Filed 2020·Granted Mar 5, 2024·0 cites·8 claims
- 3677US7608694B2Antibody molecules having specificity for human IL-1βUCB PHARMA SA·Filed 2004·Granted Oct 27, 2009·8 cites·21 claims
- 3777US2021140972A1Mechanism of actionUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 3877US2021132079A1AntibodyUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 3976US2025270308A1Antibody epitopeUCB Biopharma SRL·Filed 2025·Application pending·0 cites
- 4075US9034600B2DNA encoding antibody molecules which bind IL-17A and IL-17FUCB PHARMA SA·Filed 2013·Granted May 19, 2015·1 cites·9 claims
- 4174US9394357B2Method for obtaining antibodiesLAWSON ALASTAIR DAVID GRIFFITHS·Filed 2006·Granted Jul 19, 2016·1 cites·21 claims
- 4274US9249232B2Framework selectionADAMS RALPH·Filed 2007·Granted Feb 2, 2016·1 cites·10 claims
- 4373US7790414B2Methods for producing antibodiesUCB PHARMA SA·Filed 2004·Granted Sep 7, 2010·2 cites·9 claims
- 4471US4085428AApparatus for recording and reproducing information with respect to a flexible recording mediumBURROUGHS CORP·Filed 1976·Granted Apr 18, 1978·15 cites·8 claims
- 4569US2022025033A1Antibody epitopeUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 4667US11942188B2Obtaining an improved therapeutic ligandUCB Biopharma SRL·Filed 2020·Granted Mar 26, 2024·0 cites·19 claims
- 4767US10479824B2Single chain FC polypeptidesLAWSON ALASTAIR DAVID GRIFFITHS·Filed 2007·Granted Nov 19, 2019·1 cites·9 claims
- 4865US2018346561A1Antibody molecules which bind il-17a and il-17fUCB BIOPHARMA SPRL·Filed 2018·Application pending·0 cites
- 4964US9738710B2Method of treating a patient for pain by administering an anti-ion channel antibodyUCB BIOPHARMA SPRL·Filed 2014·Granted Aug 22, 2017·0 cites·10 claims
- 5061US9840556B2Anti-TNF alpha antibodies which selectively inhibit TNF alpha signalling through the p55RBROWN DEREK THOMAS·Filed 2005·Granted Dec 12, 2017·1 cites·10 claims
Showing the top 50 of 69 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →